Blood thinner showdown: which single drug works best after stents?

NCT ID NCT06691191

Recruiting now Disease control Sponsor: University of Florida Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two blood thinners, prasugrel and ticagrelor, when used alone after stopping aspirin in people with coronary artery disease who have had a stent placed. About 48 participants will take one of the two drugs for three weeks to see which one better prevents blood clotting. The goal is to find out if one drug is as good as or better than the other when used by itself.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: prasugrel and ticagrelor (blood thinners)
What this could lead to: If successful, this could show that one of these blood thinners works better than the other when used alone, potentially simplifying treatment after stent placement.
What could go wrong: This is a small, early-phase study with only 48 participants, so results may not apply to everyone. It measures lab effects, not real-world outcomes like heart attacks or strokes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE

Contacts and locations

Locations

University of Florida Jacksonville
RECRUITING

Jacksonville, Florida, 32209, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.